Rac1 inhibition to sensitize triple negative breast cancer to EGFR inhibition.

被引：0
|
作者：
Azzi, Georges
Goka, Erik
Senderoff, Dana
Lippman, Marc E.
机构：
[1] Univ Miami, Sylvester Canc Ctr, Miami, FL USA
[2] Univ Miami, Miami, FL USA
[3] Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
10.1200/jco.2015.33.15_suppl.1084
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1084
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Rac1 inhibition as a therapeutic strategy in breast cancer
    Senderoff, Dana
    Azzi, Georges
    Goka, Erik
    Lippman, Marc
    CANCER RESEARCH, 2016, 76
  • [2] SCD-1 blockade sensitizes triple negative breast cancer to immune checkpoint inhibition.
    Vivekanandhan, Sneha
    Trynda, Justyna
    Marlow, Laura A.
    Shreeder, Barath
    Miller, James L.
    Kase, Adam M.
    Tan, Winston
    Knutson, Keith L.
    Copland, John A.
    CANCER RESEARCH, 2021, 81 (13)
  • [3] Monitoring kinome response to EGFR inhibition in triple negative breast cancer
    Whittle, Martin C.
    Duncan, James S.
    Graves, Lee M.
    Johnson, Gary L.
    CLINICAL CANCER RESEARCH, 2012, 18 (10)
  • [4] Nanoconjugate mediated inhibition of EGFR expression of triple negative breast cancer
    Inoue, Satoshi
    Patil, Rameshwar
    Portilla, Jose
    Ding, Hui
    Konda, Bindu
    Espinoza, Andres
    Phillips, H. Westley
    Elramsisy, Adam
    Holler, Eggehard
    Black, Keith L.
    Ljubimova, Julia
    CANCER RESEARCH, 2011, 71
  • [5] Inhibition of RPTOR overcomes resistance to EGFR inhibition in triple-negative breast cancer cells
    You, Kyu Sic
    Yi, Yong Weon
    Kwak, Sahng-June
    Seong, Yeon-Sun
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2018, 52 (03) : 828 - 840
  • [6] Nanobiopolymer for Direct Targeting and Inhibition of EGFR Expression in Triple Negative Breast Cancer
    Inoue, Satoshi
    Patil, Rameshwar
    Portilla-Arias, Jose
    Ding, Hui
    Konda, Bindu
    Espinoza, Andres
    Mongayt, Dmitriy
    Markman, Janet L.
    Elramsisy, Adam
    Phillips, H. Westley
    Black, Keith L.
    Holler, Eggehard
    Ljubimova, Julia Y.
    PLOS ONE, 2012, 7 (02):
  • [7] Inhibition of triple-negative breast cancer models by combinations of antibodies to EGFR
    Ferraro, Daniela A.
    Gaborit, Nadege
    Maron, Ruth
    Cohen-Dvashi, Hades
    Porat, Ziv
    Pareja, Fresia
    Lavi, Sara
    Lindzen, Moshit
    Ben-Chetrit, Nir
    Sela, Michael
    Yarden, Yosef
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (05) : 1815 - 1820
  • [8] Synthetic Lethal Interactions Between EGFR and PARP Inhibition in Triple Negative Breast Cancer
    Nowsheen, S.
    Cooper, T.
    LoBuglio, A. F.
    Bonner, J. A.
    Yang, E. S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S176 - S177
  • [9] Enhanced intrinsic migration of aggressive breast cancer cells by inhibition of Rac1 GTPase
    Zuo, Yufeng
    Shields, Sarah-Kim
    Chakraborty, Chandan
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 351 (02) : 361 - 367
  • [10] RAC1 INHIBITION FOR THE TREATMENT OF MEDULLOBLASTOMA
    Ayad, Nagi
    Jangde, Nitish
    NEURO-ONCOLOGY, 2024, 26
12345